Walleye Trading
ABVX

Walleye Trading’s Abivax ABVX Stock Holding History

Walleye Trading’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26M Buy
20,300
+12,800
+171% +$1.51M ﹤0.01% 1631
2025
Q4 		$1.01M Buy
+7,500
New +$818K ﹤0.01% 2373

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Walleye Trading's ABVX Position: Q1 2026 in Review

Walleye Trading reduced its Abivax (ABVX) stake by 45% in Q1 2026, selling an estimated $961K and leaving 9,769 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2104.

Walleye Trading first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.41M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Walleye Trading held 9,769 shares of Abivax worth $1.09M as of Q1 2026.
  • Walleye Trading sold 8,117 Abivax shares in Q1 2026, an estimated $961K.
  • Abivax made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2104 holding.
  • Walleye Trading first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Walleye Trading's Abivax position peaked at $2.41M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.